Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

Y Cheng, C He, M Wang, X Ma, F Mo, S Yang… - Signal transduction and …, 2019‏ - nature.com
Epigenetic alternations concern heritable yet reversible changes in histone or DNA
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …

[HTML][HTML] Non-coding RNAs as regulators in epigenetics

JW Wei, K Huang, C Yang… - Oncology reports, 2017‏ - spandidos-publications.com
Epigenetics is a discipline that studies heritable changes in gene expression that do not
involve altering the DNA sequence. Over the past decade, researchers have shown that …

Matrix metalloproteinases inhibitors in cancer treatment: an updated review (2013–2023)

S Almutairi, HM Kalloush, NA Manoon, SK Bardaweel - Molecules, 2023‏ - mdpi.com
Matrix metalloproteinases (MMPs) are identifiable members of proteolytic enzymes that can
degrade a wide range of proteins in the extracellular matrix (ECM). MMPs can be …

[HTML][HTML] The roles of MicroRNA in lung cancer

KL Wu, YM Tsai, CT Lien, PL Kuo, JY Hung - International journal of …, 2019‏ - mdpi.com
Lung cancer is the most devastating malignancy in the world. Beyond genetic research,
epigenomic studies—especially investigations of microRNAs—have grown rapidly in …

Anti-inflammatory microRNAs and their potential for inflammatory diseases treatment

A Tahamtan, M Teymoori-Rad, B Nakstad… - Frontiers in …, 2018‏ - frontiersin.org
Inflammation is a complicated biological and pathophysiological cascade of responses to
infections and injuries, and inflammatory mechanisms are closely related to many diseases …

MicroRNA as biomarkers and diagnostics

J Wang, J Chen, S Sen - Journal of cellular physiology, 2016‏ - Wiley Online Library
MicroRNAs (miRNAs) are a group of small non‐coding RNAs that are involved in regulating
a range of developmental and physiological processes; their dysregulation has been …

The role of epigenetics in autoimmune/inflammatory disease

AEA Surace, CM Hedrich - Frontiers in immunology, 2019‏ - frontiersin.org
Historically, systemic self-inflammatory conditions were classified as either autoinflammatory
and caused by the innate immune system or autoimmune and driven by adaptive immune …

Micro-RNA: The darkhorse of cancer

M Budakoti, AS Panwar, D Molpa, RK Singh… - Cellular signalling, 2021‏ - Elsevier
The discovery of micro RNAs (miRNA) in cancer has opened up new vistas for researchers
in recent years. Micro RNAs area set of small, endogenous, highly conserved, non-coding …

MicroRNA (miRNA) in cancer

KB Reddy - Cancer cell international, 2015‏ - Springer
In recent years, there has been a tremendous and growing interest among researchers to
investigate the role of mircoRNA (miRNA) in normal cellular as well as in disease processes …

MicroRNAs and other non-coding RNAs as targets for anticancer drug development

H Ling, M Fabbri, GA Calin - Nature reviews Drug discovery, 2013‏ - nature.com
The first cancer-targeted microRNA (miRNA) drug—MRX34, a liposome-based miR-34
mimic—entered Phase I clinical trials in patients with advanced hepatocellular carcinoma in …